Thrombolysis after acute myocardial infarction

Emergency Medicine Journal

Volumn 14, Issue 1, 1997, Pages 2-9

  Nee, Patrick A ^a,b  

^a WHISTON HOSPITAL   (United Kingdom)

^b Dept Accident Emergency Med C ^*  (United Kingdom)

Author keywords

Acute myocardial infarcarion, streptokinase; rt PA; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANISTREPLASE; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE;

ACUTE HEART INFARCTION; BLEEDING; BLOOD CLOT LYSIS; DRUG COST; HEART ARRHYTHMIA; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; ORAL DRUG ADMINISTRATION; REVIEW; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION; TIME;

ANISTREPLASE; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; PLASMINOGEN ACTIVATORS; STREPTOKINASE; THROMBOLYTIC THERAPY;

EID: 0031031757     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.14.1.2     Document Type: Review

References (49)

1. Tillett WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J Exp Med 1933;58:485-502.
2. Christensen LR, Macleod CM. A proteolytic enzyme of serum:characterization, activation and reaction with inhibitors. J Gen Physiol 1945;28:559-83
3. Sherry S. The origin of thrombolytic therapy, J Am Coll Cardiol 1989;14.1085- 92.
4. Fletcher AP, Alkjaersig N, Smyrniotis FE, Sherry S. Treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Physicians 1958;71:287-96.
5. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, et al Prevalerice of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897- 902.
6. Rentrop P, Blanke H, Kostering K, Karsch KR. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase in combination with transluminal recanalization. Clin Cardiol 1979;2:354-63.
7. Schroder R, Biamino G, Von Leitner ER, Linderer T, Brüggemann T, Heitz J, et al. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation 1983;63:536-48.
8. Smith RAG, Dupe RJ, English PD, Green J. Fibnnolysis with acyl enzymes' a new approach to thrombolvtic therapy. Nature 1981;290:505-8.
9. Ryken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in tissue culture. J Biol Chem 1981;256:7035-41.
10. GISSI (Gruppo Italiano per lo Studio della Sopravvienza nell Infarto Miocardico). Effectiveness of intravenous thrombolvtic treatment in acute myocardial infarction. Lancet 1986;i:397-401.
11. ISIS-2 (second international study of infarct survival) Collaberative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;ii:349-60.
12. AIMS (APSAC intervention mortality study) Trial Study Group. Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988;i:545-9.
13. R Wilcox RG, Von Der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR for the ASSET (Anglo-Scandinavian study of early thrombolysis) study group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Lancet 1988;ii: 525-30.
14. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
15. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction and improved survival: should the paradigm be expanded? Circulation 1989;79:441.
16. ISIS-3 (Third International Study of Infarct Survival) Collaberative Group. A randomized trial of streptokinase vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70.
17. Muller DWM, Topol EJ. Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med 1990;113:949-60.
18. ISAM (Intravenous Streptokinase in Acute Myocardial Infarction) Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction: mortality, morbidity and infarct size at 21 days. N Engl J Med 1986; 314:1465-71.
19. Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, et al. Age related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell Infarto miocardico (GISSI 2). N Engl J Med 1993;329:1442-8.
20. Krumholz HM, Pasternak RC, Weinstein MC, Friesinger GC, Ridker PM, Tostenson AN, et al Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med 1992;327:7-13.
21. Elliott JM, Cross DB, Cederholm-Williams SA, White HD. Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy. Am J Cardiol 1993;71: 640-5.
22. Rawles J. Deciding who should have thrombolysis (letter). BMJ 1993;307:799- 80.
23. Channer KS. Deciding who should have thrombolysis letter). BMJ 1993,307:1146.
24. LATE (Late Assessment of Thrombolytic Efficacy) Study Group. Late assessment of thrombolytic efficacy with altiplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-66.
25. Cross SJ, Lee SH, Rawles JM, Jennings K. Safety of thrombolysis in association with cardiopulmonary resuscitation. BMJ 1991;303:1241.
26. Scholz KH, Tebbe U, Herrmann C, Wojcik J, Lingen R, Chemnitius JM, et al. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am J Cardiol 1992;69:724-8.
27. Weston CFM, Avery P Thrombolysis following pre-hospital cardiopulmonary resuscitation. Int J Cardiol 1992;37. 195-8.
28. Tenaglia AN, Califf RM, Candela RJ, Kereiakes DJ, Berrios E, Young SY, et al. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. Am J Cardiol 1991;68 1015-9.
29. Risenfors M, Gustavsson G, Ekstrorn L, Hartford M, Herlintz J, Karlson BW, et al. Prehospital thrombolysis in suspected acute myocardial infarction:Results from the TEAHAT study. J Intern Med 1991,734(suppl): 3-10.
30. GREAT Group, Feasibility, safety and efficacy of domiciliary thrombolysis by General Practitioners: Grampian Region early anistreplase trial. BMJ 1992;305:548-58.
31. EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaberative Group. Randomized trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 1993;342:767-72.
32. GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
33. Chesbro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I. a comparison between intravenous tissue plasminogen activator and intravenous streptokinase Clinical findings through hospital discharge. Circulation 1987;76:142-54.
34. O'Donnell M. Battle of the clotbusters. BMJ 1991;302: 1259-61.
35. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO) Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
36. Global utilisation of streptokinase and tissue plasminogen for occluded coronary arteries (GUSTO) investigators.The effects of tisssue plasminogen activator, streptokinase or both on coronary artery patency,ventricular function and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
37. Lee KL, Califf RM, Simes J, Van der Werf F, Topol EJ. Holding GUSTO up to the light: global utilisation of streptokinase and tissue plasminogen activator for occluded coronary arteries. Ann Intern Med 1994;120:876-81.
38. Leizorovicz A, Boissel JP, Julian D, Castaigne A, Haugh MC (The European Myocardial Infarction Project Group). Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329:383-9.
39. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, et al, for the Myocardial Infarction Triage and Intervention (MITI) Project Group. Prehospital-initiated versus hospital-initiated thrombolytic therapy. JAMA 1993;270:1211-6.
40. Weaver WD, Eisenberg MS, Martin JS, Litwin PE, Shaeffer SM, Ho MT, et al. Myocardial Infarction Triage and Intervention Project - phase 1: patient characteristics and feasibility of prehosptial initiation of thrombolytic therapy. J Am Coll Cardiol 1990;15:925-31.
41. Pell ACH, Miller HC. Delays in admission of patients with acute myocardial infarction to coronary care:Implications for thrombolysis. Health Bull 1990;48:225-31.
42. Rawles J. Halving of mortality at one year by domicilliary thrombolysis in the Grampion Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1994;23:1-5.
43. Weston CFM, Penny WJ, Julian DG, on behalf of the British Heart Foundation working Group.Guidelines for the early management of patients with myocardial infarction BMJ 1994;308:767-71.
44. Eisenberg MS. Reducing the door to drug interval for thrombolytic therapy. Acad Emerg Med 1995;2:579-80.
45. Pell ACH, Miller HC, Robertson CE, Fox KAA. Effect of 'fast track' admission for acute myocardial infarction on delay to thrombolysis. BMJ 1992;304:83-7.
46. Birkhead JS. Time delays in provision of thrombolytic treatment in six district hospitals. Joint Audit Commitee of the British Cardiac Society and a cardiological commitee of the Royal College of Physicians of London BMJ 1992;305: 445-8.
47. Nee PA, Gray AJG, Martin MAM. Audit of thrombolysis initiated in an accident and emergency department. Quality in Health Care 1994;2:29-33
48. Vincent R. Advances in the early diagnosis and management of acute myocardial infarction. J Accid Emerg Med 1996; 13:74-9.
49. Mulrow CD. Rationale for systematic reviews. In: Chalmers I, Altman DG, eds. Systematic reviews. London; BMJ publishing group, 1995.